We then observed the effect of the nanoinhibitor on tumor cells with different expression levels of gasdermin, where gasdermin-underexpressed HGC-27 cells developed non-pyroptotic morphology after treatment with the nanoinhibitor (Fig. S5D). This evidence concerns the gene GSDMA and neoplasm.